Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates

References

• Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN, Lucet IS, et al. 2012. Suppression of cytokine signaling by SOCS3: Characterization of the mode of inhibition and the basis of its specificity. Immunity 36:239–250
   PubMed Web of Science ®Google Scholar
• Babon JJ, McManus EJ, Yao S, DeSouza DP, Mielke LA, Sprigg NS, Willson TA, et al. 2006. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell 22:205–216
   PubMed Web of Science ®Google Scholar
• Babon JJ, Nicola NA. 2012. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factor 30:207–219
   PubMed Web of Science ®Google Scholar
• Babon JJ, Sabo JK, Soetopo A, Yao S, Bailey MF, Zhang JG, Nicola NA, Norton RS. 2008. The SOCS box domain of SOCS3: Structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol 381:928–940
   PubMed Web of Science ®Google Scholar
• Babon JJ, Sabo JK, Zhang JG, Nicola NA, Norton RS. 2009. The SOCS box encodes a hierarchy of affinities for Cullin5: Implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol 387:162–174
   PubMed Web of Science ®Google Scholar
• Babon JJ, Yao S, DeSouza DP, Harrison CF, Fabri LJ, Liepinsh E, Scrofani SD, et al. 2005. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain. FEBS J 272:6120–6130
   PubMed Web of Science ®Google Scholar
• Boyle K, Egan P, Rakar S, Willson TA, Wicks IP, Metcalf D, Hilton DJ, et al. 2007. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110:1466–1474
   PubMed Web of Science ®Google Scholar
• Brzovic PS, Klevit RE. 2006. Ubiquitin transfer from the E2 perspective -- Why is UbcH5 so promiscuous? Cell Cycle 5:2867–2873
   PubMed Web of Science ®Google Scholar
• Bullock AN, Debreczeni JE, Edwards AM, Sundstrom M, Knapp S. 2006. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc Natl Acad Sci USA 103:7637–7642
   PubMed Web of Science ®Google Scholar
• Bullock AN, Rodriguez MC, Debreczeni JE, Songyang Z, Knapp S. 2007. Structure of the SOCS4-elonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. Structure 15:1493–1504
   PubMed Web of Science ®Google Scholar
• Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540–545
   PubMed Web of Science ®Google Scholar
• Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, DiRago L, Cluse LA, et al. 2004. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20:153–165
   PubMed Web of Science ®Google Scholar
• De Sepulveda P, Ilangumaran S, Rottapel R. 2000. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J Biol Chem 275:14005–14008
   PubMedGoogle Scholar
• Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. 2008. Structural insights into NEDD8 activation of cullin-RING ligases: Conformational control of conjugation. Cell 134:995–1006
   PubMed Web of Science ®Google Scholar
• Hilton DJ. 1999. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55:1568–1577
   PubMed Web of Science ®Google Scholar
• Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, et al. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 95:114–119
   PubMed Web of Science ®Google Scholar
• Hochstrasser M. 2006. Lingering mysteries of ubiquitin-chain assembly. Cell 124:27–34
   PubMed Web of Science ®Google Scholar
• Hori T, Osaka F, Chiba T, Miyamoto C, Okabayashi K, Shimbara N, Kato S, Tanaka K. 1999. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 18:6829–6834
   PubMed Web of Science ®Google Scholar
• Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, Scott DC, Borg LA, et al. 2009. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell 33:483–495
   PubMed Web of Science ®Google Scholar
• Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, et al. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276:12530–12538
   PubMed Web of Science ®Google Scholar
• Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, Lucet IS, et al. 2013. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol 20:469–476
   PubMed Web of Science ®Google Scholar
• Kim HT, Kim KP, Lledias F, Kisselev AF, Scaglione KM, Skowyra D, Gygi SP, Goldberg AL. 2007. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 282:17375–17386
   PubMed Web of Science ®Google Scholar
• Kuang Z, Lewis RS, Curtis JM, Zhan Y, Saunders BM, Babon JJ, Kolesnik TB, et al. 2010. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation. J Cell Biol 190:129–141
   PubMed Web of Science ®Google Scholar
• Lucet IS, Fantino E, Styles M, Bamert R, Patel O, Broughton SE, Walter M, et al. 2006. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood 107:176–183
   PubMed Web of Science ®Google Scholar
• Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, et al. 2004. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10:739–743
   PubMed Web of Science ®Google Scholar
• Muniz JR, Guo K, Kershaw NJ, Ayinampudi V, von Delft F, Babon JJ, Bullock AN. 2013. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases. J Mol Biol 425:3166–3277
   Google Scholar
• Nicholson SE, De Souza D, Fabri LJ, Corbin J, Willson TA, Zhang JG, Silva A, et al. 2000. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 97:6493–6498
   PubMed Web of Science ®Google Scholar
• Petroski MD, Deshaies RJ. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9–20
   PubMed Web of Science ®Google Scholar
• Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, et al. 2001. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA 98:9324–9329
   PubMed Web of Science ®Google Scholar
• Rui LY, Yuan MS, Frantz D, Shoelson S, White MF. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394–42398
   PubMed Web of Science ®Google Scholar
• Saha A, Deshaies RJ. 2008. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 32:21–31
   PubMed Web of Science ®Google Scholar
• Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A. 2000. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 275:29338–29347
   PubMed Web of Science ®Google Scholar
• Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, et al. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339–351
   PubMed Web of Science ®Google Scholar
• Wenzel DM, Stoll KE, Klevit RE. 2011. E2s: Structurally economical and functionally replete. Biochem J 433:31–42
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, et al. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18:1309–1320
   PubMed Web of Science ®Google Scholar
• Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056–1060
   PubMed Web of Science ®Google Scholar
• Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, et al. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071–2076
   PubMed Web of Science ®Google Scholar
• Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, et al. 2002. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416:703–709
   PubMed Web of Science ®Google Scholar